| Literature DB >> 28188794 |
Yasuaki Uehara1, Motoko Takahashi2, Masaki Murata3, Atsushi Saito1, Rina Takamiya2, Yoshihiro Hasegawa1, Koji Kuronuma4, Hirofumi Chiba4, Jiro Hashimoto5, Norimasa Sawada3, Hiroki Takahashi4, Yoshio Kuroki2, Shigeru Ariki6.
Abstract
Human β-defensin 3 (hBD3) is known to be involved in mast cell activation. However, molecular mechanisms underlying the regulation of hBD3-induced mast cell activation have been poorly understood. We previously reported that SP-A and SP-A-derived peptide 01 (SAP01) regulate the function of hBD3. In this study, we focused on the effects of SP-A and SAP01 on the activation of mast cells induced by hBD3. SAP01 directly bound to hBD3. Mast cell-mediated vascular permeability and edema in hBD3 administered rat ears were decreased when injected with SP-A or SAP01. Compatible with the results in rat ear model, both SP-A and SAP01 inhibited hBD3-induced chemotaxis of mast cells in vitro. Direct interaction between SP-A or SAP01 and hBD3 seemed to be responsible for the inhibitory effects on chemotaxis. Furthermore, SAP01 attenuated hBD3-induced accumulation of mast cells and eosinophils in tracheas of the OVA-sensitized inflammatory model. SP-A might contribute to the regulation of inflammatory responses mediated by mast cells during infection.Entities:
Keywords: Chemotaxis; Human β-defensin 3; Mast cells; Surfactant protein A
Mesh:
Substances:
Year: 2017 PMID: 28188794 DOI: 10.1016/j.bbrc.2017.02.028
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575